glp-1 employer coverage news october 2025 insurance worsened at start of 2025, report says GLP-1 Drugs: 2025 Pulse Survey

The broader clinical impact must be considered, especially for populations with cardiometabolic disease

They include : Nausea Constipation Vomiting Diarrhea Burping (eructation) Indigestion (dyspepsia) Stomach pain Headache Fatigue Reflux Flatulence (gas) Hair loss As with other GLP-1s, more serious side effects are possible, such as an inflamed pancreas or low blood sugar (hypoglycemia)

By slowing gastric emptying and enhancing the bodys satiety response, these medications may help decrease cravings and improve portion control, making medically supervised weight loss more achievable for appropriate candidates

you are getting access to specialists who understand these nuances